51 related articles for article (PubMed ID: 30318338)
1. Protein Kinase C Epsilon Deletion in Adipose Tissue, but Not in Liver, Improves Glucose Tolerance.
Brandon AE; Liao BM; Diakanastasis B; Parker BL; Raddatz K; McManus SA; O'Reilly L; Kimber E; van der Kraan AG; Hancock D; Henstridge DC; Meikle PJ; Cooney GJ; James DE; Reibe S; Febbraio MA; Biden TJ; Schmitz-Peiffer C
Cell Metab; 2019 Jan; 29(1):183-191.e7. PubMed ID: 30318338
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease.
Samuel VT; Liu ZX; Wang A; Beddow SA; Geisler JG; Kahn M; Zhang XM; Monia BP; Bhanot S; Shulman GI
J Clin Invest; 2007 Mar; 117(3):739-45. PubMed ID: 17318260
[TBL] [Abstract][Full Text] [Related]
3. The tumor suppressor TMEM127 regulates insulin sensitivity in a tissue-specific manner.
Srikantan S; Deng Y; Cheng ZM; Luo A; Qin Y; Gao Q; Sande-Docor GM; Tao S; Zhang X; Harper N; Shannon CE; Fourcaudot M; Li Z; Kasinath BS; Harrison S; Ahuja S; Reddick RL; Dong LQ; Abdul-Ghani M; Norton L; Aguiar RCT; Dahia PLM
Nat Commun; 2019 Oct; 10(1):4720. PubMed ID: 31624249
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to "Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis" [Mol Metab 69 (2023) 1-13].
Dehondt H; Marino A; Butruille L; Mogilenko DA; Nzoussi Loubota AC; Chávez-Talavera O; Dorchies E; Vallez E; Haas J; Derudas B; Bongiovanni A; Tardivel M; Kuipers F; Lefebvre P; Lestavel S; Tailleux A; Dombrowicz D; Caron S; Staels B
Mol Metab; 2024 May; ():101961. PubMed ID: 38802064
[No Abstract] [Full Text] [Related]
5. Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes.
Clemmensen C; Jall S; Kleinert M; Quarta C; Gruber T; Reber J; Sachs S; Fischer K; Feuchtinger A; Karlas A; Simonds SE; Grandl G; Loher D; Sanchez-Quant E; Keipert S; Jastroch M; Hofmann SM; Nascimento EBM; Schrauwen P; Ntziachristos V; Cowley MA; Finan B; Müller TD; Tschöp MH
Nat Commun; 2018 Oct; 9(1):4304. PubMed ID: 30353008
[TBL] [Abstract][Full Text] [Related]
6. Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue.
Petrus P; Mejhert N; Corrales P; Lecoutre S; Li Q; Maldonado E; Kulyté A; Lopez Y; Campbell M; Acosta JR; Laurencikiene J; Douagi I; Gao H; Martínez-Álvarez C; Hedén P; Spalding KL; Vidal-Puig A; Medina-Gomez G; Arner P; Rydén M
Cell Rep; 2018 Oct; 25(3):551-560.e5. PubMed ID: 30332637
[TBL] [Abstract][Full Text] [Related]
7. Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis.
Soberanes S; Misharin AV; Jairaman A; Morales-Nebreda L; McQuattie-Pimentel AC; Cho T; Hamanaka RB; Meliton AY; Reyfman PA; Walter JM; Chen CI; Chi M; Chiu S; Gonzalez-Gonzalez FJ; Antalek M; Abdala-Valencia H; Chiarella SE; Sun KA; Woods PS; Ghio AJ; Jain M; Perlman H; Ridge KM; Morimoto RI; Sznajder JI; Balch WE; Bhorade SM; Bharat A; Prakriya M; Chandel NS; Mutlu GM; Budinger GRS
Cell Metab; 2019 Feb; 29(2):335-347.e5. PubMed ID: 30318339
[TBL] [Abstract][Full Text] [Related]
8. Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1.
Koh A; Molinaro A; Ståhlman M; Khan MT; Schmidt C; Mannerås-Holm L; Wu H; Carreras A; Jeong H; Olofsson LE; Bergh PO; Gerdes V; Hartstra A; de Brauw M; Perkins R; Nieuwdorp M; Bergström G; Bäckhed F
Cell; 2018 Nov; 175(4):947-961.e17. PubMed ID: 30401435
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin.
Sun L; Xie C; Wang G; Wu Y; Wu Q; Wang X; Liu J; Deng Y; Xia J; Chen B; Zhang S; Yun C; Lian G; Zhang X; Zhang H; Bisson WH; Shi J; Gao X; Ge P; Liu C; Krausz KW; Nichols RG; Cai J; Rimal B; Patterson AD; Wang X; Gonzalez FJ; Jiang C
Nat Med; 2018 Dec; 24(12):1919-1929. PubMed ID: 30397356
[TBL] [Abstract][Full Text] [Related]
10. Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition.
Varin EM; Mulvihill EE; Beaudry JL; Pujadas G; Fuchs S; Tanti JF; Fazio S; Kaur K; Cao X; Baggio LL; Matthews D; Campbell JE; Drucker DJ
Cell Metab; 2019 Feb; 29(2):320-334.e5. PubMed ID: 30393019
[TBL] [Abstract][Full Text] [Related]
11. Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk.
Cirulli ET; Guo L; Leon Swisher C; Shah N; Huang L; Napier LA; Kirkness EF; Spector TD; Caskey CT; Thorens B; Venter JC; Telenti A
Cell Metab; 2019 Feb; 29(2):488-500.e2. PubMed ID: 30318341
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity.
Kubota T; Inoue M; Kubota N; Takamoto I; Mineyama T; Iwayama K; Tokuyama K; Moroi M; Ueki K; Yamauchi T; Kadowaki T
Nat Commun; 2018 Nov; 9(1):4863. PubMed ID: 30451856
[TBL] [Abstract][Full Text] [Related]
13. The deubiquitinating enzyme USP19 modulates adipogenesis and potentiates high-fat-diet-induced obesity and glucose intolerance in mice.
Coyne ES; Bédard N; Gong YJ; Faraj M; Tchernof A; Wing SS
Diabetologia; 2019 Jan; 62(1):136-146. PubMed ID: 30386869
[TBL] [Abstract][Full Text] [Related]
14. Disruption of beta cell acetyl-CoA carboxylase-1 in mice impairs insulin secretion and beta cell mass.
Cantley J; Davenport A; Vetterli L; Nemes NJ; Whitworth PT; Boslem E; Thai LM; Mellett N; Meikle PJ; Hoehn KL; James DE; Biden TJ
Diabetologia; 2019 Jan; 62(1):99-111. PubMed ID: 30334081
[TBL] [Abstract][Full Text] [Related]
15. A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance.
Lyu K; Zhang Y; Zhang D; Kahn M; Ter Horst KW; Rodrigues MRS; Gaspar RC; Hirabara SM; Luukkonen PK; Lee S; Bhanot S; Rinehart J; Blume N; Rasch MG; Serlie MJ; Bogan JS; Cline GW; Samuel VT; Shulman GI
Cell Metab; 2020 Oct; 32(4):654-664.e5. PubMed ID: 32882164
[TBL] [Abstract][Full Text] [Related]
16. Deconstructing the Role of PKC Epsilon in Glucose Homeostasis.
Schmitz-Peiffer C
Trends Endocrinol Metab; 2020 May; 31(5):344-356. PubMed ID: 32305097
[TBL] [Abstract][Full Text] [Related]
17. Hexokinase-linked glycolytic overload and unscheduled glycolysis in hyperglycemia-induced pathogenesis of insulin resistance, beta-cell glucotoxicity, and diabetic vascular complications.
Rabbani N; Thornalley PJ
Front Endocrinol (Lausanne); 2023; 14():1268308. PubMed ID: 38292764
[TBL] [Abstract][Full Text] [Related]
18. Inter-organ crosstalk during development and progression of type 2 diabetes mellitus.
Xourafa G; Korbmacher M; Roden M
Nat Rev Endocrinol; 2024 Jan; 20(1):27-49. PubMed ID: 37845351
[TBL] [Abstract][Full Text] [Related]
19. Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus-The Chicken or the Egg Dilemma.
Kosmalski M; Śliwińska A; Drzewoski J
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189715
[TBL] [Abstract][Full Text] [Related]
20. The crucial role and mechanism of insulin resistance in metabolic disease.
Zhao X; An X; Yang C; Sun W; Ji H; Lian F
Front Endocrinol (Lausanne); 2023; 14():1149239. PubMed ID: 37056675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
